The DOI matches its Crossref record.
The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Schirrmacher, V. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4661 · Cited by 1,296
The growing role of precision and personalized medicine for cancer treatment
Krzyszczyk, P., Acevedo, A., Davidoff, E. J., Timmins, L. M., Marrero-Berrios, I., Patel, M., White, C., Lowe, C., Sherba, J. J., Hartmanshenn, C., et al. (2018) · TECHNOLOGY · doi:10.1142/s2339547818300020 · Cited by 698
Riedl, S., Zweytick, D., & Lohner, K. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.09.004 · Cited by 405
Scorpion venom components as potential candidates for drug development
Ortiz, E., Gurrola, G. B., Schwartz, E. F., & Possani, L. D. (2015) · Toxicon · doi:10.1016/j.toxicon.2014.11.233 · Cited by 335
Riedl, S., Rinner, B., Asslaber, M., Schaider, H., Walzer, S., Novak, A., Lohner, K., & Zweytick, D. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.026 · Cited by 331
Contemporary Challenges in the Design of Topoisomerase II Inhibitors for Cancer Chemotherapy
Bailly, C. (2012) · Chemical Reviews · doi:10.1021/cr200325f · Cited by 288
Saevarsdottir, T., Fridriksdottir, N., & Gunnarsdottir, S. (2010) · Cancer Nursing · doi:10.1097/ncc.0b013e3181b4adb5 · Cited by 68
“Although chemotherapy may prolong survival modestly in advanced cancer,4 conventional cytotoxic chemotherapy has proven unable to cure most cancers after they have metastasized, and in fact, an investigation of the contribution of chemotherapy to 5-year survival in adults showed an estimation of 2.3% in Australia and…”
BackgroundInfluentialShee, K., Wells, J. D., Jiang, A., & Miller, T. W. (2019) · PLOS ONE · doi:10.1371/journal.pone.0224267 · Cited by 43
“However, there is a large heterogeneity of response to chemotherapy, and retrospective analysis of clinical response data shows that a large proportion of patients do not derive benefit from chemotherapy [2, 3].”
Background
Metadata
- Authors
- Morgan, G., Ward, R., & Barton, M.
- Venue
- Clinical Oncology
- Publisher
- Elsevier BV
- Published
- 2004-12
- Volume
- 16
- Issue
- 8
- Pages
- 549-560
- ISSN
- 0936-6555 (ISSN-L)
- OpenAlex
- W2163126616
- Cited by
- 221
- References
- 0
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.